NASDAQ:CBMG - Cellular Biomedicine Group SEC Filings & 10K Form

$14.94
-0.05 (-0.33 %)
(As of 06/24/2019 03:24 PM ET)
Today's Range
$14.94
Now: $14.94
$15.00
50-Day Range
$14.18
MA: $16.08
$17.41
52-Week Range
$12.04
Now: $14.94
$25.00
Volume23 shs
Average Volume32,984 shs
Market Capitalization$270.26 million
P/E RatioN/A
Dividend YieldN/A
Beta2.69

SEC Filings

Cellular Biomedicine Group (NASDAQ:CBMG) SEC Filings

DateFilerForm TypeView
06/17/2019
7:23 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/16/2019
4:20 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/30/2019
4:01 PM
Cellular Biomedicine Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
04/29/2019
8:27 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/25/2019
8:44 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/23/2019
8:24 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/28/2019
10:33 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/22/2019
8:31 PM
Cellular Biomedicine Group (Filer)
Form 424B5
View Filing
03/22/2019
4:29 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/20/2019
3:20 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/20/2019
3:11 PM
Cellular Biomedicine Group (Filer)
Form 424B5
View Filing
03/15/2019
4:13 PM
Cellular Biomedicine Group (Filer)
Form DEFA14A
View Filing
03/15/2019
4:11 PM
Cellular Biomedicine Group (Filer)
Form DEF 14A
View Filing
03/01/2019
10:05 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/19/2019
4:01 PM
Cellular Biomedicine Group (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/14/2019
8:53 PM
Cellular Biomedicine Group (Issuer)
Chan Andrew K (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
View Filing
02/14/2019
8:50 PM
Cellular Biomedicine Group (Issuer)
Liu Tony (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
View Filing
02/14/2019
8:48 PM
Cellular Biomedicine Group (Issuer)
Yao Yihong (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
View Filing
01/25/2019
3:45 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/17/2019
5:30 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/09/2019
7:00 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/28/2018
3:11 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/10/2018
1:10 PM
Cellular Biomedicine Group (Subject)
Dangdal International Group Co. Ltd (Filed by)
Form SC 13D/A
View Filing
11/06/2018
5:26 AM
Cellular Biomedicine Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
10/29/2018
7:07 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/23/2018
8:16 AM
Cellular Biomedicine Group (Filer)
Form 424B3
View Filing
10/22/2018
11:15 PM
Cellular Biomedicine Group (Filer)
Form EFFECT
View Filing
10/18/2018
3:13 PM
Cellular Biomedicine Group (Filer)
Form CT ORDER
View Filing
10/18/2018
3:06 PM
Cellular Biomedicine Group (Filer)
Form CT ORDER
View Filing
10/10/2018
6:11 PM
Cellular Biomedicine Group (Filer)
Form S-3
Registration statement under Securities Act of 1933  
View Filing
10/10/2018
7:30 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/09/2018
4:27 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/02/2018
7:00 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/28/2018
3:33 PM
Cellular Biomedicine Group (Subject)
NOVARTIS PHARMA AG (Filed by)
Form SC 13G
View Filing
09/27/2018
6:45 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/22/2018
8:00 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/22/2018
3:10 PM
Cellular Biomedicine Group (Issuer)
Hau Bosun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/22/2018
3:10 PM
Au Chun Kwok Alan (Reporting)
Cellular Biomedicine Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/22/2018
3:10 PM
Cellular Biomedicine Group (Issuer)
Patel Nadir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/22/2018
3:10 PM
Belmont Terry (Reporting)
Cellular Biomedicine Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/22/2018
3:10 PM
Cellular Biomedicine Group (Issuer)
Ji Gang Jacky (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/22/2018
3:10 PM
Cellular Biomedicine Group (Issuer)
Zhou Hansheng (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/07/2018
4:27 PM
Cellular Biomedicine Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
04/30/2018
8:11 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/23/2018
7:42 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/19/2018
7:33 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/12/2018
3:05 PM
Cellular Biomedicine Group (Issuer)
Liu Wen Tao (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/11/2018
3:11 PM
Cellular Biomedicine Group (Filer)
Form 424B3
View Filing
04/09/2018
11:15 PM
Cellular Biomedicine Group (Filer)
Form EFFECT
View Filing
04/02/2018
3:17 PM
Cellular Biomedicine Group (Filer)
Form S-3/A
View Filing
03/16/2018
8:56 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/13/2018
11:40 AM
Cellular Biomedicine Group (Issuer)
Hau Bosun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/12/2018
4:29 PM
Cellular Biomedicine Group (Filer)
Form DEFA14A
View Filing
03/12/2018
4:15 PM
Cellular Biomedicine Group (Filer)
Form DEF 14A
View Filing
03/06/2018
12:31 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/05/2018
3:51 PM
Cellular Biomedicine Group (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/01/2018
2:26 PM
Cellular Biomedicine Group (Subject)
Full Moon Resources Ltd (Filed by)
Form SC 13G/A
View Filing
02/15/2018
5:02 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/14/2018
12:14 PM
Cellular Biomedicine Group (Subject)
Sailing Capital Overseas Investments Fund, LP (Filed by)
Form SC 13D
View Filing
02/13/2018
5:05 PM
Cellular Biomedicine Group (Issuer)
Meng Xia (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
View Filing
02/13/2018
4:37 PM
Cellular Biomedicine Group (Issuer)
Hau Bosun (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
02/02/2018
10:57 AM
Cellular Biomedicine Group (Filer)
Form D
Notice of Exempt Offering of Securities 
View Filing
02/01/2018
3:46 PM
Cellular Biomedicine Group (Subject)
Maplebrook Ltd (Filed by)
Form SC 13G
View Filing
01/31/2018
7:47 AM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/28/2017
3:32 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/27/2017
4:08 PM
Cellular Biomedicine Group (Issuer)
Yao Yihong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/27/2017
4:08 PM
Cellular Biomedicine Group (Issuer)
Liu Tony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/27/2017
4:08 PM
Cellular Biomedicine Group (Issuer)
Chan Andrew K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/21/2017
3:06 PM
Cellular Biomedicine Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
This page was last updated on 6/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel